Diabetes Center at UCSF - Sang-Mo Kang, M.D.

Overview Basic Science Translational Research Clinical Research Islet Transplantation Publications List Training Opportunities Diabetes Research Links The Hormone Research Institute The Metabolic Research Unit

Diabetes Endocrinology Research Center (DERC)

DERC was established to support and enhance interactions among an outstanding team of investigators involved in Type 1 or 2 diabetes research.

UCSF JDRF CENTER (CCCT)

The mission of the center is to develop and test a new approach to the treatment of Type 1 diabetes by bringing together researchers from 5 academic institutions and 1 commercial partner.

Sang-Mo Kang, M.D.

Kang SM; Schneider DB; Lin Z; Hanahan D; Dichek DA; Stock PG; Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Medicine, 1997 Jul, 3(7):738-43.

Kang SM; Hoffmann A; Le D; Springer ML; Stock PG; Blau HM. Immune response and myoblasts that express Fas ligand. Science, 1997 Nov 14, 278(5341):1322-4.

O'Rourke RW, Kang SM, Lower, JA, Feng S, Ascher NL, Baekkeskov S, Stock PG. A dendritic cell line genetically modified to express CTLA4-Ig as a means to prolong islet allograft survival. . Transplantation. 2000 Apr 15;69(7):1440-6.

Kang SM; Braat D; Schneider DB; O'Rourke R; Lin Z; Ascher NL; Dichek DA; Baekkeskov S; and Stock PG. A non - cleavable mutant of Fas Ligand does not prevent neutrophilic destruction of islet transplants. Transplantation. 2000 May 15;69(9):1813-7.